Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Abbott’s new 2.25mm diameter stent prepares for launch in Europe, Asia and Latin America

Abbott Vascular : 11 March, 2008  (New Product)
Abbott has received CE Mark approval for a 2.25mm version of its Xience V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and deliverability of Xience V.
The addition of the 2.25 mm Stent to the Xience V portfolio gives physicians access to a wider range of Stent sizes for treating a variety of patient types.

'Lesions in small vessels tend to be more complex and challenging to treat, so it is important to have a drug eluting Stent with proven clinical benefits that can be easily delivered to the diseased area of the vessel,' said Charles Simonton, MD, FACC, FSCAI, divisional vice president, Medical Affairs and chief medical officer, Abbott Vascular. 'With Xience V 2.25mm, physicians now have access to a smaller Stent that combines these critical attributes with the positive safety outcomes we have seen with Xience V. These outcomes include low rates of re-intervention in the diseased vessel, low rates of heart attack and death, and low rates of vessel re-narrowing following treatment.'

The 2.25mm version of the Xience V Stent will be launched immediately in the majority of European markets and select countries in Asia and Latin America. In addition to the 2.25mm stent, Xience V is available in Stent diameters of 2.5mm, 2.75mm, 3.0mm, 3.5mm and 4.0mm for lesions 28mm or shorter.

Coronary artery disease (CAD) occurs when arteries become narrow due to plaque buildup, restricting blood flow to the heart. Approximately 30 to 40 percent of CAD lesions occur in vessels equal to or less than 2.5mm in diameter.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo